This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Lincoln National & Swiss Life to Enhance Benefits Solutions
by Zacks Equity Research
Lincoln National (LNC) intends to facilitate benefits solutions for employees by collaborating with Swiss Life Network.
Is MetLife (MET) a Suitable Stock for Value Investors Now?
by Zacks Equity Research
Let's see if MetLife (MET) stock is a good choice for value-oriented investors right now from multiple angles.
MetLife Joins PlanSource Boost to Enhance Benefits Experience
by Zacks Equity Research
MetLife (MET) extends relation with PlanSource to improve the benefits experience on the back of real-time API integrations.
MetLife Unit Reaches Longevity Reinsurance Agreement With PIC
by Zacks Equity Research
MetLife's (MET) subsidiary Metropolitan Tower Life Insurance Company inks a deal to penetrate the U.K. longevity reinsurance market.
MetLife (MET) Up 14.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Company News for May 8, 2020
by Zacks Equity Research
Companies In The News Are: TWLO, FTNT, MET, TMUS.
MetLife's (MET) Q1 Earnings Top Estimates, Revenues Lag
by Sapna Bagaria
MetLife's (MET) Q1 earnings beat estimates on the back of revenue rise and higher net investment income, partly offset by elevated expenses.
MetLife (MET) Q1 Earnings Beat Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 8.97% and -7.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stock Q1 Earnings Due on May 6: MET, RE & More
by Tanuka De
Insurers in the first quarter are likely to have suffered from low interest rates and charges from the COVID-19 impact but benefited from strong top lines driven by their vast and diversified businesses.
Why MetLife (MET) Might Surprise This Earnings Season
by Zacks Equity Research
MetLife (MET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for MetLife (MET) This Earnings Season?
by Zacks Equity Research
MetLife's (MET) Q1 earnings are likely to have gained from higher premiums, partly offset by lower investment income.
What's in Store for Allstate (ALL) This Earnings Season?
by Zacks Equity Research
Allstate's (ALL) Q1 earnings are likely to have gained from higher premiums, partly offset by catastrophe loss and elevated marketing expense.
Earnings Preview: MetLife (MET) Q1 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Life Insurers' Outlook Bleak Amid Coronavirus-Led Economic Blip
by Sapna Bagaria
Life insurers are likely to suffer a setback in business due to economic weakness caused by the COVID-19 pandemic. Low interest rates are another concern.
Progressive Refunds Premium to Members on Reduced Driving
by Zacks Equity Research
Progressive (PGR) intends to relieve its members of financial burden amid the crisis as it is witnessing reduced driving.
Cincinnati Rewards Customers With Part Premium Amid the Crisis
by Zacks Equity Research
Cincinnati (CINF) plans to credit premiums to its auto insurance customers, which, in turn, is likely to relieve clients of financial stress during the pandemic.
Chubb (CB) to Reward Customers Owing to Reduced Driving
by Zacks Equity Research
Chubb (CB) intends to lower the financial burden of its clients as it is witnessing reduced driving.
MetLife's Unit Refunds Premiums to Members Amid the Crisis
by Zacks Equity Research
MetLife (MET) undertakes several measures to aid its members amid the coronavirus pandemic.
Radian Group Steps Up Safety Measures Amid Coronavirus Outbreak
by Zacks Equity Research
Radian Group (RDN) takes precautionary steps against the novel coronavirus pandemic to ensure safety of its employees and customers.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is the Options Market Predicting a Spike in MetLife (MET) Stock?
by Zacks Equity Research
Investors need to pay close attention to MetLife (MET) stock based on the movements in the options market lately.
MetLife Hurt by Low Interest Rates, Equity Market Declines
by Sapna Bagaria
MetLife's (MET) exposure to life insurance business weighs on the stock as macro-economic volatility is likely to mar its earnings and capital level.
Will Underperforming Japan Business Weigh on Aflac (AFL)?
by Zacks Equity Research
Low interest rates and sales misconduct accusation on Japan Post weigh on Aflac's (AFL) business growth.
MetLife (MET) Down 21.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Upbeat Near-Term Outlook for Multiline Insurance Industry
by Sapna Bagaria
Rise in insurance rates for most business lines, product upgrade, strong capital levels and investment in technology are expected to bode well for Mutiline insurers.